Your browser doesn't support javascript.
loading
Structural brain anomalies in patients with FOXG1 syndrome and in Foxg1+/- mice.
Pringsheim, Milka; Mitter, Diana; Schröder, Simone; Warthemann, Rita; Plümacher, Kim; Kluger, Gerhard; Baethmann, Martina; Bast, Thomas; Braun, Sarah; Büttel, Hans-Martin; Conover, Elizabeth; Courage, Carolina; Datta, Alexandre N; Eger, Angelika; Grebe, Theresa A; Hasse-Wittmer, Annette; Heruth, Marion; Höft, Karen; Kaindl, Angela M; Karch, Stephanie; Kautzky, Torsten; Korenke, Georg C; Kruse, Bernd; Lutz, Richard E; Omran, Heymut; Patzer, Steffi; Philippi, Heike; Ramsey, Keri; Rating, Tina; Rieß, Angelika; Schimmel, Mareike; Westman, Rachel; Zech, Frank-Martin; Zirn, Birgit; Ulmke, Pauline A; Sokpor, Godwin; Tuoc, Tran; Leha, Andreas; Staudt, Martin; Brockmann, Knut.
Afiliação
  • Pringsheim M; Klinik für Neuropädiatrie und Neurologische Rehabilitation Epilepsiezentrum für Kinder und Jugendliche Schön Klinik Vogtareuth Vogtareuth Germany.
  • Mitter D; Research Institute "Rehabilitation, Transition, Rehabilitation" Paracelsus Medical University Salzburg Austria.
  • Schröder S; Institute of Human Genetics University of Leipzig Medical Center Leipzig Germany.
  • Warthemann R; Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders University Medical Center Göttingen Göttingen Germany.
  • Plümacher K; Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders University Medical Center Göttingen Göttingen Germany.
  • Kluger G; Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders University Medical Center Göttingen Göttingen Germany.
  • Baethmann M; Klinik für Neuropädiatrie und Neurologische Rehabilitation Epilepsiezentrum für Kinder und Jugendliche Schön Klinik Vogtareuth Vogtareuth Germany.
  • Bast T; Research Institute "Rehabilitation, Transition, Rehabilitation" Paracelsus Medical University Salzburg Austria.
  • Braun S; Sozialpädiatrisches Zentrum Klinikum Dritter Orden München Germany.
  • Büttel HM; Epilepsiezentrum Kork Kehl-Kork Germany.
  • Conover E; Medical Faculty University of Freiburg Freiburg Germany.
  • Courage C; Asklepios Children's Hospital St. Augustin Germany.
  • Datta AN; Sozialpädiatrisches Zentrum SLK-Kliniken Heilbronn Heilbronn Germany.
  • Eger A; Department of Genetic Medicine Munroe Meyer Institute University of Nebraska Medical Center Omaha Omaha Nebraska USA.
  • Grebe TA; Division of Human Genetics Department of Pediatrics, Inselspital University of Bern Bern Switzerland.
  • Hasse-Wittmer A; The Folkhälsan Institute of Genetics University of Helsinki Helsinki Finland.
  • Heruth M; Department of Pediatric Neurology and Developmental Medicine University of Basel Children's Hospital Basel Switzerland.
  • Höft K; Sozialpädiatrisches Zentrum Leipzig (Frühe Hilfe Leipzig) Leipzig Germany.
  • Kaindl AM; Division of Genetics and Metabolism Phoenix Children's Hospital Phoenix Arizona USA.
  • Karch S; Klinikum Traunstein Traunstein Germany.
  • Kautzky T; Klinik für Kinder- und Jugendmedizin Sana Kliniken Leipziger Land Borna Germany.
  • Korenke GC; Klinik für Kinder- und Jugendmedizin Klinikum Magdeburg gGmbH Magdeburg Germany.
  • Kruse B; Klinik für Pädiatrie m.S. Neurologie Sozialpädiatrisches Zentrum Institut für Zell- und Neurobiologie Charité-Universitätsmedizin Berlin Berlin Germany.
  • Lutz RE; Klinik für Kinder- und Jugendmedizin Sozialpädiatrisches Zentrum Universitätsklinikum Heidelberg Heidelberg Germany.
  • Omran H; Klinikum Leer Leer Germany.
  • Patzer S; Klinik für Neuropädiatrie und angeborene Stoffwechselerkrankungen Elisabeth Kinderkrankenhaus Klinikum Oldenburg Germany.
  • Philippi H; Neuropediatric Department Helios-Klinikum Hildesheim Hildesheim Germany.
  • Ramsey K; Department of Genetic Medicine Munroe Meyer Institute University of Nebraska Medical Center Omaha Omaha Nebraska USA.
  • Rating T; Department of General Pediatrics University Children's Hospital Muenster Muenster Germany.
  • Rieß A; Klinik für Kinder- und Jugendmedizin Krankenhaus St. Elisabeth und St. Barbara Halle/Saale Germany.
  • Schimmel M; Sozialpädiatrisches Zentrum Frankfurt Mitte Frankfurt am Main Germany.
  • Westman R; Center for Rare Childhood Disorders Translational Genomics Research Institute Phoenix Arizona USA.
  • Zech FM; Sozialpädiatrisches Institut Klinikum Bremen-Mitte Bremen Germany.
  • Zirn B; Institut für Medizinische Genetik und angewandte Genomik Universitätsklinikum Tübingen Tübingen Germany.
  • Ulmke PA; Children's Hospital Section of Neuropaediatrics Klinikum Augsburg Augsburg Germany.
  • Sokpor G; Children's Specialty Center St. Luke's Children's Hospital Boise Idaho USA.
  • Tuoc T; Klinik für Kinder- und Jugendmedizin St. Vincenz-Krankenhaus Paderborn Paderborn Germany.
  • Leha A; Genetic Counselling and Diagnostic, genetikum Stuttgart Stuttgart Germany.
  • Staudt M; Institute of Neuroanatomy University Medical Center Georg August University Göttingen Germany.
  • Brockmann K; Institute of Neuroanatomy University Medical Center Georg August University Göttingen Germany.
Ann Clin Transl Neurol ; 6(4): 655-668, 2019 Apr.
Article em En | MEDLINE | ID: mdl-31019990
ABSTRACT

OBJECTIVE:

FOXG1 syndrome is a rare neurodevelopmental disorder associated with heterozygous FOXG1 variants or chromosomal microaberrations in 14q12. The study aimed at assessing the scope of structural cerebral anomalies revealed by neuroimaging to delineate the genotype and neuroimaging phenotype associations.

METHODS:

We compiled 34 patients with a heterozygous (likely) pathogenic FOXG1 variant. Qualitative assessment of cerebral anomalies was performed by standardized re-analysis of all 34 MRI data sets. Statistical analysis of genetic, clinical and neuroimaging data were performed. We quantified clinical and neuroimaging phenotypes using severity scores. Telencephalic phenotypes of adult Foxg1+/- mice were examined using immunohistological stainings followed by quantitative evaluation of structural anomalies.

RESULTS:

Characteristic neuroimaging features included corpus callosum anomalies (82%), thickening of the fornix (74%), simplified gyral pattern (56%), enlargement of inner CSF spaces (44%), hypoplasia of basal ganglia (38%), and hypoplasia of frontal lobes (29%). We observed a marked, filiform thinning of the rostrum as recurrent highly typical pattern of corpus callosum anomaly in combination with distinct thickening of the fornix as a characteristic feature. Thickening of the fornices was not reported previously in FOXG1 syndrome. Simplified gyral pattern occurred significantly more frequently in patients with early truncating variants. Higher clinical severity scores were significantly associated with higher neuroimaging severity scores. Modeling of Foxg1 heterozygosity in mouse brain recapitulated the associated abnormal cerebral morphology phenotypes, including the striking enlargement of the fornix.

INTERPRETATION:

Combination of specific corpus callosum anomalies with simplified gyral pattern and hyperplasia of the fornices is highly characteristic for FOXG1 syndrome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fatores de Transcrição Forkhead / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Animals / Female / Humans Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Fatores de Transcrição Forkhead / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Animals / Female / Humans Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2019 Tipo de documento: Article